Medical Devices & Diagnostics

Embracing a healthier and sustainable tomorrow with intelligent healthcare enabled through a virtual-first business model, disruptive innovations, and an evolved ecosystem.

tab-icon Surgical tab-icon IVD tab-icon Imaging tab-icon Therapeutics
Virtual and augmented reality
Teleoperative surgery
Miniaturized in-vivo robots
Surgical robots
3D printing
Smart implants
Digital twin

Surgical

In the coming decade, the growth of the surgical equipment market will be decided by its ability to penetrate underdeveloped economies and advanced digitalization through surgical robots, digital twins, smart implants, 3D printing, and such. Profit margins and ROI will be decided by companies’ ability to meet the rising geriatric population’s requirements, optimal waste management, and local competition. Costing will remain a decisive factor in the tussle between robotic and handheld surgical devices. Effective price control strategies and innovation will be the key to gaining an edge in markets. Product and production standards will keep inclining towards sustainability and better waste management. Focusing on these two factors will help industry participants fare well against market pressures.

Microfluidics & nanotechnology-empowered POCT
Next-generation sequencing (NGS) techniques
AI & IoT based analytics…
Diagnostics workflow automation
Personalized & Precision medicine
Biomarker screening using AI-ML
Blockchain technology

IVD

Testing “democratization” is pivotal in pushing the post-pandemic growth of the IVD market. The path ahead will be defined by strategic repositioning platforms that were earlier used for SARS-CoV-2 testing. The rise in chronic diseases and awareness about lifestyle diseases calls for specific and speedy solutions and smart integration of advanced technologies like cancer biomarker screening using AI-ML. Rapid integration of digitalization mandates the application of hi-tech safety measures like blockchain technology. Molecular diagnostics, mass spectrometry, fecal occult blood, inherited diseases testing, and glucose monitoring will be some of the key trends that will drive the growth of this industry in the coming years.

AI, ML & DL Based…
Workflow automation & orchestration
Web-Based imaging systems/ applications
Wearable imaging
Mobile medical imaging
Multi-modal imaging
VR and AR based medical…

Imaging

Despite accounting for 90% of healthcare data, the medical imaging industry struggles to align itself with emerging technologies. Companies aiming to expand their profit margins must prioritize resources, digital transformation, and long-term investment in emerging technologies. There is an eminent need to extract data in organizational silos and some standard acquisition protocols. A large segment of the workforce in this industry lacks familiarity with new trends like blockchain technology, multi-modal imaging, VR and AR-based medical imaging, etc. The true fruits of AI implementation can only be achieved with a standards-equipped approach toward interoperability. Transferring imaging data to cloud-based infrastructure will work best for those who can adhere to DICOM standards and provide DICOM-native services.

Digital pills
Implantable AI platforms
Drug delivery robots
AI-based clinical decision support
Telemedicine/Telehealth
Remote patient monitoring
Telepsychiatry

Therapeutics

The therapeutics industry has an unparalleled appetite for manufacturing and scientific advancement. But for now, the biggest challenge is product differentiation and better reimbursement for products made to mainstream channels. The target users are still confused between wellness concepts and therapeutic products. Companies planning to strengthen their position in this domain must strategize in this direction. Clarity on payment pathways, reimbursement policy barriers, and cybersecurity risks are significant roadblocks barring the acceptance of therapeutic innovations like telepsychiatry, remote patient monitoring, telemedicine, etc.

Surgical IVD Imaging Therapeutics

Surgical

In the coming decade, the growth of the surgical equipment market will be decided by its ability to penetrate underdeveloped economies and advanced digitalization through surgical robots, digital twins, smart implants, 3D printing, and such. Profit margins and ROI will be decided by companies’ ability to meet the rising geriatric population’s requirements, optimal waste management, and local competition. Costing will remain a decisive factor in the tussle between robotic and handheld surgical devices. Effective price control strategies and innovation will be the key to gaining an edge in markets. Product and production standards will keep inclining towards sustainability and better waste management. Focusing on these two factors will help industry participants fare well against market pressures.

IVD

Testing “democratization” is pivotal in pushing the post-pandemic growth of the IVD market. The path ahead will be defined by strategic repositioning platforms that were earlier used for SARS-CoV-2 testing. The rise in chronic diseases and awareness about lifestyle diseases calls for specific and speedy solutions and smart integration of advanced technologies like cancer biomarker screening using AI-ML. Rapid integration of digitalization mandates the application of hi-tech safety measures like blockchain technology. Molecular diagnostics, mass spectrometry, fecal occult blood, inherited diseases testing, and glucose monitoring will be some of the key trends that will drive the growth of this industry in the coming years.

Imaging

Despite accounting for 90% of healthcare data, the medical imaging industry struggles to align itself with emerging technologies. Companies aiming to expand their profit margins must prioritize resources, digital transformation, and long-term investment in emerging technologies. There is an eminent need to extract data in organizational silos and some standard acquisition protocols. A large segment of the workforce in this industry lacks familiarity with new trends like blockchain technology, multi-modal imaging, VR and AR-based medical imaging, etc. The true fruits of AI implementation can only be achieved with a standards-equipped approach toward interoperability. Transferring imaging data to cloud-based infrastructure will work best for those who can adhere to DICOM standards and provide DICOM-native services.

Therapeutics

The therapeutics industry has an unparalleled appetite for manufacturing and scientific advancement. But for now, the biggest challenge is product differentiation and better reimbursement for products made to mainstream channels. The target users are still confused between wellness concepts and therapeutic products. Companies planning to strengthen their position in this domain must strategize in this direction. Clarity on payment pathways, reimbursement policy barriers, and cybersecurity risks are significant roadblocks barring the acceptance of therapeutic innovations like telepsychiatry, remote patient monitoring, telemedicine, etc.

Innovative Technologies Value Creation Business Excellence Strategic Consulting
Sustainability Business Models Value Chain Digitalization Commercialization GTM (Go-to-Market) Consumer/Customer Analysis Commercialization Partners Value Chain Assessment Product Launch Excellence Product Portfolio Assessment Infringement Analysis Out-licensing Validation Best-fit Analysis Market Assessment Buy vs Build Decision Risk Assessment Demand & Supply Analysis Regulatory Assessment Competitive Advantage Analysis Prototyping & Implementation Strategic Implementation Roadmap Partners Scouting Capex & Opex Assessment VoC Analysis Commercialization Assessment Ideation Idea Funnel Management Ideation & Mapping Early Innovation Research Prior-art search Patentability Search/Novelty Search Feasibility VoC Analysis Consumer Dynamics Market Assessment Customer Identification Target Market Identification Idea Benchmarking Financial Viability Freedom to Operate Scouting Technology Scouting Partner Scouting Competitive Intelligence Early Innovation Research Technology In-licensing Horizon Scan Weak Signal Scan Techno-Commercial Foresighting Innovation Scan Investment Opportunity Scan Novel Business Models Industry Trend Monitoring
Ideation Feasibility Scouting Validation Prototyping & Implementation Commercialization Horizon Scan

Our Ecosystem Partners

R&D and Technology Providers
Pre-Clinical & Clinical Testing Players
Contract Developers & Manufacturers
Supply Chain Partners
Market Access Partners
Health Service Providers
Payers and Insurers
Regulators

How We Support Our Partners

img img

What Our Partners Say

We have now reviewed the report and we are happy with the outline and content. Glad to see that you added a bit more information related to mode of action. It was really easy to read and search so I do not see a need for any follow up meetings. We now have plenty of inspiration to use for our future planning and assessments. We would want to thank you for a great job and for sharing back a very clear and easily digestible report and table.
Of course, no worry we have had great experience with the Stellarix team. Indeed, we are very happy with the study Stellarix did for us. We are still exploiting it and do learn from it in our strategy exercises. Thanks again for all the great work Stellarix is doing and thus providing previous and highly valued help for our business decisions!
Thank you and your team for the report. We spent some time to go through it and we are impressed! It was very good meeting as well to discuss the report. We are impressed by the overall capabilities of Stellarix. I will consult with my colleagues and hope to follow up with more projects.
Thanks for this final report. I believe now it has been really formatted in a very user friendly manner. I thank you and team Stellarix for such an excellent compilation of the contents related to the current topic and look forward to work with you on other topics in future.
You and your colleagues did some very useful work, and we turned the results over to our lawyers to get their views as early as possible, we will be in touch for follow-up work.
Thank you for your report. We checked your results, and we are sure that our invention is completely different from them. Thanks for your precious collaboration. Thanks a lot for your work, we really appreciated your study.
I am pleased to confirm that we have sourced a number of materials of interest that you identified and are running them though our screens. The leads you identified have certainly broadened our range of options as desired. We are satisfied with the final report and no further action is required as of now.
profile
R&D Director
Healthcare Pharmaceutical Company
profile
Global Director
Animal Health Nutrition Company
profile
Head of R&D
Nutrition & Biosciences Company
profile
Principal Innovation Lead
Cosmetics Company
profile
Research Head
Telecommunications Company
profile
R&D Director
Cosmetics Company
profile
R&D Leader
Oral Care